CatholicULeuven
Leuven, 3000, Belgium
NCT Number: NCT02287207
The purpose of this pilot study is to determine the effect of transcranial direct current stimulation (tDCS) on brain activity and fine motor skills in patients with Parkinson's disease compared to healthy controls.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Leuven, 3000, Belgium
The pilot study will involve a double-blind, sham controlled cross-over design where participants will receive anodal and sham tDCS stimulation in a randomized order. Differences in brain activity and fine motor skill performance between groups and after tDCS stimulation will be compared.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: post-stimulation (immediately after) and retention (1 week)
Centimeter (cm)
Time frame: post-stimulation (immediately after) and retention (1 week)
Centimeter per second (cm/s)
Time frame: post-stimulation (immediately after) and retention (1 week)
Number of pegs placed in 30 seconds
Time frame: post-stimulation (immediately after) and retention (1 week)
Motor Evoked Potentials (MEP) peak to peak amplitude and latency - Measured with single-pulse Transcranial Magnetic
Time frame: post-stimulation (immediately after) and retention (1 week)
Measured with double-pulse Transcranial Magnetic Stimulation (TMS)
Time frame: post-stimulation (immediately after) and retention (1 week)
Measured with single-pulse Transcranial Magnetic
KU Leuven
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03648905
Autonomic Failure, Autonomic Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01621581
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05699460
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Irvine, California, United States
View Trial DetailsNCT07720869
Basal Ganglia Diseases, Brain Diseases
Baton Rouge, Louisiana, United States
View Trial Details